tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
RNA
Atrium Therapeutics, Inc.
RESEARCH TOOLSreports

Atrium Therapeutics, Inc. (RNA) Income Statement

6 Followers

Atrium Therapeutics, Inc. Income Statement

Last quarter (Q4 2025), Atrium Therapeutics, Inc.'s total revenue was $859.00K, a decrease of -71.11% from the same quarter last year. In Q4, Atrium Therapeutics, Inc.'s net income was $-48.07M. See Atrium Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 18.62M$ 10.90M$ 9.56M$ 9.22M$ 9.33M
Gross Profit
$ 18.62M$ 10.90M$ 7.46M$ 7.84M$ -91.86M
Operating Expenses
$ 95.43M$ 389.83M$ 243.06M$ 186.75M$ 26.20M
Depreciation and Amortization
$ 323.00K$ 2.78M$ 2.10M$ 1.39M$ 639.00K
EBITDA
$ -76.49M$ -376.16M$ -233.50M$ -177.53M$ -117.41M
Operating Income
$ -76.81M$ -378.94M$ -235.60M$ -178.91M$ -118.05M
Other Income/Expenses
$ -12.00K$ 56.63M$ 23.38M$ 4.92M$ 42.00K
Pretax Income
$ -76.83M$ -322.30M$ -212.22M$ -174.00M$ -118.01M
Net Income
$ -76.68M$ -322.30M$ -212.22M$ -174.00M$ -118.01M
Per Share Metrics
Basic EPS
$ -4.48$ -2.89$ -2.91$ -3.34$ -2.85
Diluted EPS
$ -4.48$ -2.89$ -2.91$ -3.34$ -2.85
Weighted Average Shares Outstanding
 17.11M 111.58M 73.01M 52.16M 41.43M
Weighted Average Shares Outstanding (Diluted)
 17.11M 111.58M 73.01M 52.16M 41.43M
Currency in USD

Atrium Therapeutics, Inc. Earnings and Revenue History